Concepts (352)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surgical Flaps | 38 | 2015 | 887 | 5.840 |
Why?
|
| Free Tissue Flaps | 20 | 2016 | 374 | 2.780 |
Why?
|
| Thigh | 14 | 2014 | 164 | 2.350 |
Why?
|
| Trachea | 9 | 2013 | 297 | 1.750 |
Why?
|
| Pharynx | 7 | 2014 | 150 | 1.500 |
Why?
|
| Pharyngectomy | 6 | 2012 | 43 | 1.420 |
Why?
|
| Esophagus | 9 | 2014 | 562 | 1.330 |
Why?
|
| Laryngeal Neoplasms | 9 | 2015 | 529 | 1.250 |
Why?
|
| Laryngectomy | 8 | 2015 | 243 | 1.220 |
Why?
|
| Tongue Neoplasms | 5 | 2015 | 253 | 0.910 |
Why?
|
| Tissue Scaffolds | 3 | 2013 | 134 | 0.880 |
Why?
|
| Head and Neck Neoplasms | 15 | 2014 | 4140 | 0.870 |
Why?
|
| Neck | 5 | 2011 | 393 | 0.860 |
Why?
|
| Perforator Flap | 2 | 2014 | 96 | 0.800 |
Why?
|
| Gallbladder | 9 | 2001 | 68 | 0.770 |
Why?
|
| Postoperative Complications | 18 | 2015 | 5675 | 0.750 |
Why?
|
| Microsurgery | 8 | 2014 | 235 | 0.740 |
Why?
|
| Extracellular Matrix | 2 | 2013 | 523 | 0.700 |
Why?
|
| Carcinoma, Squamous Cell | 10 | 2015 | 5589 | 0.700 |
Why?
|
| Cervicoplasty | 3 | 2009 | 4 | 0.640 |
Why?
|
| Esophagectomy | 4 | 2014 | 946 | 0.640 |
Why?
|
| Head | 3 | 2011 | 248 | 0.620 |
Why?
|
| Pharyngeal Diseases | 3 | 2007 | 51 | 0.600 |
Why?
|
| Cutaneous Fistula | 3 | 2007 | 45 | 0.600 |
Why?
|
| Recovery of Function | 10 | 2014 | 684 | 0.590 |
Why?
|
| Graft Rejection | 6 | 2016 | 845 | 0.570 |
Why?
|
| Bone Transplantation | 5 | 2013 | 149 | 0.560 |
Why?
|
| Glossectomy | 4 | 2015 | 43 | 0.560 |
Why?
|
| Jejunum | 4 | 2012 | 228 | 0.560 |
Why?
|
| Ultrasonography, Doppler | 2 | 2016 | 275 | 0.550 |
Why?
|
| Deglutition | 6 | 2015 | 187 | 0.540 |
Why?
|
| Forearm | 4 | 2011 | 70 | 0.530 |
Why?
|
| Oral Fistula | 2 | 2005 | 9 | 0.530 |
Why?
|
| Muscle Contraction | 9 | 2001 | 229 | 0.500 |
Why?
|
| Pharyngeal Neoplasms | 2 | 2006 | 142 | 0.490 |
Why?
|
| Tissue and Organ Harvesting | 3 | 2011 | 127 | 0.490 |
Why?
|
| Anastomosis, Surgical | 5 | 2012 | 371 | 0.490 |
Why?
|
| Esophagoplasty | 2 | 2012 | 28 | 0.490 |
Why?
|
| Aged | 43 | 2016 | 73375 | 0.480 |
Why?
|
| Graft Survival | 9 | 2016 | 1081 | 0.480 |
Why?
|
| Middle Aged | 50 | 2016 | 90334 | 0.460 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2014 | 57 | 0.450 |
Why?
|
| Cholecystokinin | 5 | 1998 | 51 | 0.450 |
Why?
|
| Male | 61 | 2016 | 128374 | 0.440 |
Why?
|
| Angiography | 2 | 2012 | 350 | 0.430 |
Why?
|
| Tissue Engineering | 4 | 2013 | 255 | 0.420 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 522 | 0.420 |
Why?
|
| Muscle, Smooth | 6 | 2001 | 251 | 0.410 |
Why?
|
| Prostheses and Implants | 2 | 2016 | 294 | 0.410 |
Why?
|
| Mandible | 2 | 2010 | 191 | 0.390 |
Why?
|
| Adult | 38 | 2016 | 81975 | 0.380 |
Why?
|
| Female | 55 | 2016 | 148945 | 0.370 |
Why?
|
| Acellular Dermis | 1 | 2012 | 101 | 0.370 |
Why?
|
| Reoperation | 8 | 2016 | 1391 | 0.370 |
Why?
|
| Osteoradionecrosis | 2 | 2010 | 128 | 0.370 |
Why?
|
| Speech Disorders | 2 | 2015 | 85 | 0.370 |
Why?
|
| Epigastric Arteries | 1 | 2010 | 45 | 0.360 |
Why?
|
| Esophageal Diseases | 1 | 2011 | 78 | 0.360 |
Why?
|
| Esthetics | 1 | 2010 | 116 | 0.360 |
Why?
|
| Neuroma | 1 | 2010 | 11 | 0.350 |
Why?
|
| Tracheal Neoplasms | 1 | 2010 | 44 | 0.350 |
Why?
|
| Rectus Abdominis | 1 | 2010 | 92 | 0.350 |
Why?
|
| Skull Base | 1 | 2011 | 225 | 0.350 |
Why?
|
| Tracheostomy | 3 | 2010 | 248 | 0.350 |
Why?
|
| Groin | 1 | 2010 | 78 | 0.350 |
Why?
|
| Mouth Floor | 1 | 2009 | 14 | 0.340 |
Why?
|
| Lower Extremity | 1 | 2012 | 286 | 0.330 |
Why?
|
| Pelvic Exenteration | 1 | 2009 | 112 | 0.320 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2009 | 66 | 0.320 |
Why?
|
| Hemangioma | 1 | 2010 | 157 | 0.310 |
Why?
|
| Hypopharyngeal Neoplasms | 2 | 2006 | 84 | 0.310 |
Why?
|
| Prosthesis Implantation | 2 | 2010 | 242 | 0.300 |
Why?
|
| Aged, 80 and over | 18 | 2015 | 31006 | 0.300 |
Why?
|
| Length of Stay | 7 | 2012 | 2004 | 0.300 |
Why?
|
| Humans | 61 | 2016 | 270744 | 0.290 |
Why?
|
| GTP-Binding Proteins | 3 | 1998 | 342 | 0.290 |
Why?
|
| Skull Base Neoplasms | 1 | 2011 | 339 | 0.290 |
Why?
|
| Regional Blood Flow | 3 | 2016 | 285 | 0.290 |
Why?
|
| Respiratory Tract Fistula | 1 | 2007 | 34 | 0.290 |
Why?
|
| Esophageal Neoplasms | 5 | 2011 | 3240 | 0.280 |
Why?
|
| Polycythemia Vera | 1 | 2009 | 268 | 0.270 |
Why?
|
| Glottis | 1 | 2006 | 68 | 0.260 |
Why?
|
| Carcinoma, Adenoid Cystic | 2 | 2008 | 444 | 0.260 |
Why?
|
| Retrospective Studies | 23 | 2016 | 39827 | 0.260 |
Why?
|
| Treatment Outcome | 20 | 2014 | 33733 | 0.240 |
Why?
|
| Postoperative Care | 4 | 2012 | 728 | 0.240 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2012 | 916 | 0.240 |
Why?
|
| Thoracic Wall | 1 | 2006 | 188 | 0.240 |
Why?
|
| Mouth | 1 | 2005 | 124 | 0.230 |
Why?
|
| Speech | 1 | 2006 | 139 | 0.230 |
Why?
|
| Hospital Costs | 1 | 2006 | 242 | 0.230 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2015 | 10385 | 0.230 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 5 | 1998 | 27 | 0.230 |
Why?
|
| Skull | 3 | 2014 | 251 | 0.230 |
Why?
|
| Mouth Neoplasms | 1 | 2009 | 734 | 0.230 |
Why?
|
| Diglycerides | 5 | 2001 | 35 | 0.230 |
Why?
|
| Wound Healing | 6 | 2012 | 767 | 0.220 |
Why?
|
| Cholesterol | 3 | 2001 | 659 | 0.220 |
Why?
|
| Rats, Inbred Lew | 2 | 2013 | 118 | 0.220 |
Why?
|
| Skin Transplantation | 3 | 2012 | 185 | 0.200 |
Why?
|
| Scrotum | 1 | 2002 | 59 | 0.200 |
Why?
|
| Transforming Growth Factor beta | 3 | 2001 | 1109 | 0.190 |
Why?
|
| Cranial Sutures | 1 | 2001 | 34 | 0.190 |
Why?
|
| Rectal Neoplasms | 1 | 2010 | 1240 | 0.190 |
Why?
|
| Gait | 2 | 2011 | 159 | 0.190 |
Why?
|
| Logistic Models | 3 | 2016 | 3448 | 0.190 |
Why?
|
| Perineum | 1 | 2002 | 115 | 0.190 |
Why?
|
| Algorithms | 4 | 2014 | 3900 | 0.190 |
Why?
|
| Facial Nerve | 2 | 2011 | 58 | 0.190 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2001 | 66 | 0.180 |
Why?
|
| Salvage Therapy | 2 | 2015 | 2122 | 0.180 |
Why?
|
| Cholelithiasis | 3 | 2001 | 49 | 0.180 |
Why?
|
| Mastectomy | 1 | 2006 | 1553 | 0.170 |
Why?
|
| Rats | 4 | 2013 | 6525 | 0.170 |
Why?
|
| Sensitivity and Specificity | 3 | 2016 | 5171 | 0.170 |
Why?
|
| Signal Transduction | 6 | 1998 | 12102 | 0.160 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2012 | 7784 | 0.160 |
Why?
|
| Extremities | 1 | 2001 | 311 | 0.160 |
Why?
|
| Muscle, Skeletal | 4 | 2012 | 1291 | 0.160 |
Why?
|
| Adolescent | 11 | 2012 | 32735 | 0.160 |
Why?
|
| Dogs | 2 | 2010 | 1160 | 0.160 |
Why?
|
| Treatment Failure | 3 | 2014 | 1428 | 0.150 |
Why?
|
| Young Adult | 9 | 2015 | 22216 | 0.150 |
Why?
|
| Speech Intelligibility | 3 | 2015 | 40 | 0.150 |
Why?
|
| Cohort Studies | 6 | 2016 | 9473 | 0.150 |
Why?
|
| Polytetrafluoroethylene | 2 | 2010 | 109 | 0.150 |
Why?
|
| Tongue | 2 | 2008 | 85 | 0.140 |
Why?
|
| Vagina | 1 | 2009 | 331 | 0.140 |
Why?
|
| Deglutition Disorders | 2 | 2015 | 489 | 0.140 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 7383 | 0.140 |
Why?
|
| Membrane Lipids | 1 | 1996 | 47 | 0.140 |
Why?
|
| Chondrocytes | 2 | 2013 | 100 | 0.130 |
Why?
|
| Models, Animal | 2 | 2010 | 657 | 0.130 |
Why?
|
| Calmodulin | 5 | 1998 | 260 | 0.130 |
Why?
|
| Animals | 16 | 2013 | 62045 | 0.130 |
Why?
|
| Follow-Up Studies | 9 | 2015 | 15210 | 0.130 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 1312 | 0.130 |
Why?
|
| Constriction, Pathologic | 2 | 2007 | 322 | 0.130 |
Why?
|
| Orthognathic Surgical Procedures | 1 | 2014 | 22 | 0.120 |
Why?
|
| Fibula | 2 | 2012 | 152 | 0.120 |
Why?
|
| Prospective Studies | 5 | 2013 | 13414 | 0.120 |
Why?
|
| Intracellular Membranes | 1 | 1994 | 115 | 0.110 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 4328 | 0.110 |
Why?
|
| Rats, Inbred BN | 1 | 2013 | 36 | 0.110 |
Why?
|
| Microvessels | 1 | 2015 | 145 | 0.110 |
Why?
|
| Abdominal Muscles | 1 | 2014 | 71 | 0.110 |
Why?
|
| Fat Necrosis | 1 | 2014 | 60 | 0.110 |
Why?
|
| Foreign-Body Reaction | 1 | 2013 | 31 | 0.110 |
Why?
|
| Dermatofibrosarcoma | 2 | 2012 | 73 | 0.110 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 4 | 1998 | 15 | 0.110 |
Why?
|
| Quality of Life | 3 | 2010 | 4775 | 0.100 |
Why?
|
| Skull Neoplasms | 1 | 2012 | 68 | 0.100 |
Why?
|
| Mandibular Reconstruction | 1 | 2013 | 44 | 0.100 |
Why?
|
| Facial Nerve Injuries | 1 | 2011 | 10 | 0.100 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2011 | 22 | 0.100 |
Why?
|
| Sincalide | 5 | 2001 | 38 | 0.100 |
Why?
|
| Silk | 1 | 2011 | 16 | 0.100 |
Why?
|
| Fibroins | 1 | 2011 | 20 | 0.100 |
Why?
|
| Temporal Bone | 1 | 2012 | 109 | 0.100 |
Why?
|
| Sarcoma | 3 | 2012 | 1838 | 0.100 |
Why?
|
| Bioprosthesis | 1 | 2012 | 130 | 0.090 |
Why?
|
| Neoplasms | 3 | 2014 | 15919 | 0.090 |
Why?
|
| Respiratory Mucosa | 1 | 2012 | 212 | 0.090 |
Why?
|
| Cartilage | 1 | 2011 | 110 | 0.090 |
Why?
|
| Nerve Regeneration | 1 | 2011 | 118 | 0.090 |
Why?
|
| Fascia | 1 | 2010 | 55 | 0.090 |
Why?
|
| Chitosan | 1 | 2011 | 85 | 0.090 |
Why?
|
| Thyroid Neoplasms | 3 | 2006 | 1884 | 0.090 |
Why?
|
| Scalp | 1 | 2012 | 155 | 0.090 |
Why?
|
| Mandibular Diseases | 1 | 2010 | 49 | 0.090 |
Why?
|
| Facial Paralysis | 1 | 2010 | 57 | 0.090 |
Why?
|
| Polypropylenes | 1 | 2010 | 25 | 0.090 |
Why?
|
| Forehead | 1 | 2010 | 26 | 0.090 |
Why?
|
| Linear Models | 1 | 2013 | 1097 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 441 | 0.090 |
Why?
|
| Absorbable Implants | 1 | 2010 | 60 | 0.090 |
Why?
|
| Polyesters | 1 | 2010 | 68 | 0.090 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 3 | 2001 | 43 | 0.080 |
Why?
|
| Facial Neoplasms | 1 | 2010 | 77 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 621 | 0.080 |
Why?
|
| Face | 1 | 2010 | 251 | 0.080 |
Why?
|
| Morbidity | 1 | 2010 | 400 | 0.080 |
Why?
|
| Bone Neoplasms | 2 | 2012 | 2664 | 0.080 |
Why?
|
| False Positive Reactions | 1 | 2009 | 376 | 0.080 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2009 | 108 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 2 | 2006 | 4048 | 0.080 |
Why?
|
| Leiomyosarcoma | 1 | 2010 | 253 | 0.070 |
Why?
|
| Cats | 3 | 1998 | 169 | 0.070 |
Why?
|
| Speech, Alaryngeal | 1 | 2007 | 24 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 601 | 0.070 |
Why?
|
| Child | 5 | 2011 | 30538 | 0.070 |
Why?
|
| Prosthesis Design | 1 | 2010 | 654 | 0.070 |
Why?
|
| In Vitro Techniques | 4 | 2001 | 1710 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 16205 | 0.070 |
Why?
|
| Preoperative Care | 2 | 2012 | 1565 | 0.070 |
Why?
|
| Macrophages | 1 | 2013 | 1352 | 0.070 |
Why?
|
| Transplantation, Homologous | 1 | 2013 | 3043 | 0.070 |
Why?
|
| Granular Cell Tumor | 1 | 2006 | 22 | 0.070 |
Why?
|
| Mammaplasty | 1 | 2014 | 714 | 0.070 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 1757 | 0.070 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2014 | 4001 | 0.070 |
Why?
|
| Vascular Diseases | 1 | 2009 | 235 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2013 | 1875 | 0.070 |
Why?
|
| Microradiography | 1 | 2006 | 6 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2010 | 717 | 0.070 |
Why?
|
| Skin Neoplasms | 3 | 2012 | 4889 | 0.070 |
Why?
|
| Ventilators, Mechanical | 1 | 2006 | 47 | 0.070 |
Why?
|
| Cell Membrane | 3 | 2001 | 878 | 0.070 |
Why?
|
| Fasciotomy | 1 | 2006 | 51 | 0.060 |
Why?
|
| Cicatrix | 1 | 2007 | 187 | 0.060 |
Why?
|
| Oroantral Fistula | 1 | 2005 | 3 | 0.060 |
Why?
|
| Neurilemmoma | 1 | 2006 | 134 | 0.060 |
Why?
|
| Larynx, Artificial | 1 | 2005 | 44 | 0.060 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 1414 | 0.060 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2010 | 2271 | 0.060 |
Why?
|
| Benzimidazoles | 3 | 1998 | 439 | 0.060 |
Why?
|
| Neurologic Examination | 1 | 2005 | 263 | 0.060 |
Why?
|
| Bone Regeneration | 2 | 2001 | 35 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2012 | 5697 | 0.060 |
Why?
|
| Protein Kinase C | 3 | 1997 | 407 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2010 | 2363 | 0.060 |
Why?
|
| Neck Dissection | 1 | 2005 | 294 | 0.060 |
Why?
|
| Isoquinolines | 2 | 1994 | 125 | 0.060 |
Why?
|
| Combined Modality Therapy | 3 | 2015 | 9039 | 0.050 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2006 | 260 | 0.050 |
Why?
|
| Cost of Illness | 1 | 2006 | 504 | 0.050 |
Why?
|
| Thrombosis | 1 | 2009 | 743 | 0.050 |
Why?
|
| Fournier Gangrene | 1 | 2002 | 4 | 0.050 |
Why?
|
| Comorbidity | 1 | 2008 | 2392 | 0.050 |
Why?
|
| Risk Factors | 4 | 2015 | 17896 | 0.050 |
Why?
|
| Fibrosis | 1 | 2005 | 733 | 0.050 |
Why?
|
| Virulence Factors, Bordetella | 2 | 1998 | 46 | 0.050 |
Why?
|
| Pertussis Toxin | 2 | 1998 | 62 | 0.050 |
Why?
|
| Calcium | 3 | 1998 | 1588 | 0.050 |
Why?
|
| Debridement | 1 | 2002 | 119 | 0.050 |
Why?
|
| Gallbladder Emptying | 1 | 2001 | 4 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2006 | 572 | 0.050 |
Why?
|
| Tail | 1 | 2001 | 30 | 0.050 |
Why?
|
| Pressure Ulcer | 1 | 2002 | 81 | 0.050 |
Why?
|
| Forelimb | 1 | 2001 | 23 | 0.050 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2002 | 128 | 0.050 |
Why?
|
| Joints | 1 | 2001 | 44 | 0.050 |
Why?
|
| Histiocytoma, Malignant Fibrous | 2 | 2012 | 49 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2001 | 229 | 0.050 |
Why?
|
| Videotape Recording | 1 | 2001 | 75 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2010 | 6237 | 0.050 |
Why?
|
| Gallbladder Diseases | 1 | 2001 | 47 | 0.050 |
Why?
|
| Hindlimb | 1 | 2001 | 111 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 3944 | 0.050 |
Why?
|
| Parietal Bone | 1 | 2000 | 19 | 0.050 |
Why?
|
| Incidence | 1 | 2011 | 5825 | 0.050 |
Why?
|
| Culture Media | 1 | 2001 | 343 | 0.050 |
Why?
|
| Time Factors | 2 | 2012 | 13021 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 4963 | 0.040 |
Why?
|
| Sciuridae | 2 | 1997 | 8 | 0.040 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2001 | 206 | 0.040 |
Why?
|
| Aluminum Compounds | 2 | 1998 | 20 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2012 | 9290 | 0.040 |
Why?
|
| Fluorides | 2 | 1998 | 28 | 0.040 |
Why?
|
| Stents | 1 | 2006 | 999 | 0.040 |
Why?
|
| Phospholipase C beta | 1 | 1998 | 11 | 0.040 |
Why?
|
| Egtazic Acid | 1 | 1998 | 59 | 0.040 |
Why?
|
| Potassium Chloride | 1 | 1998 | 67 | 0.040 |
Why?
|
| Type C Phospholipases | 1 | 1998 | 62 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2000 | 271 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 6192 | 0.040 |
Why?
|
| Walking | 1 | 2001 | 269 | 0.040 |
Why?
|
| Hospitalization | 1 | 2007 | 2168 | 0.040 |
Why?
|
| Neoplasms, Second Primary | 1 | 2005 | 1387 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2010 | 6768 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2004 | 2238 | 0.030 |
Why?
|
| Cholesterol, Dietary | 1 | 1996 | 52 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 14012 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1998 | 651 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 2212 | 0.030 |
Why?
|
| Guinea Pigs | 3 | 2001 | 252 | 0.030 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2009 | 381 | 0.030 |
Why?
|
| Receptors, Muscarinic | 1 | 1995 | 72 | 0.030 |
Why?
|
| Progesterone | 1 | 1998 | 711 | 0.030 |
Why?
|
| Piperazines | 2 | 1994 | 2145 | 0.030 |
Why?
|
| Palliative Care | 1 | 2006 | 2178 | 0.030 |
Why?
|
| Drug Carriers | 1 | 1996 | 336 | 0.030 |
Why?
|
| Texas | 1 | 2006 | 6447 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 4374 | 0.030 |
Why?
|
| Carcinoma | 1 | 2006 | 2609 | 0.030 |
Why?
|
| Muscle Tonus | 1 | 1993 | 15 | 0.030 |
Why?
|
| Strontium | 1 | 1993 | 7 | 0.030 |
Why?
|
| Liposomes | 1 | 1996 | 704 | 0.030 |
Why?
|
| Inositol | 1 | 1993 | 27 | 0.030 |
Why?
|
| Tetrodotoxin | 1 | 1993 | 72 | 0.030 |
Why?
|
| Gastrostomy | 1 | 2015 | 196 | 0.030 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 1993 | 74 | 0.030 |
Why?
|
| Myosins | 1 | 1993 | 97 | 0.030 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 1994 | 62 | 0.030 |
Why?
|
| Palate, Hard | 1 | 2013 | 15 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 201 | 0.030 |
Why?
|
| Manometry | 1 | 2012 | 72 | 0.030 |
Why?
|
| Maxilla | 1 | 2013 | 89 | 0.030 |
Why?
|
| Pressure | 1 | 2012 | 189 | 0.030 |
Why?
|
| Gastrointestinal Motility | 1 | 2012 | 85 | 0.020 |
Why?
|
| Hemipelvectomy | 1 | 2012 | 38 | 0.020 |
Why?
|
| Mobility Limitation | 1 | 2011 | 29 | 0.020 |
Why?
|
| Contracture | 1 | 2011 | 35 | 0.020 |
Why?
|
| Orbit | 1 | 2013 | 209 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2011 | 112 | 0.020 |
Why?
|
| Abdominal Wall | 1 | 2014 | 192 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 14616 | 0.020 |
Why?
|
| Chondrogenesis | 1 | 2011 | 64 | 0.020 |
Why?
|
| Survival Rate | 2 | 2015 | 12526 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 243 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 1994 | 1811 | 0.020 |
Why?
|
| Contraindications | 1 | 2010 | 154 | 0.020 |
Why?
|
| Rabbits | 1 | 2011 | 1028 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2010 | 291 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2015 | 850 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 484 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 5070 | 0.020 |
Why?
|
| Breast | 1 | 2014 | 1370 | 0.020 |
Why?
|
| United States | 1 | 2004 | 15853 | 0.020 |
Why?
|
| Mice | 2 | 2011 | 35594 | 0.020 |
Why?
|
| Phosphorylation | 1 | 1993 | 4943 | 0.020 |
Why?
|
| Models, Biological | 1 | 1993 | 3194 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2001 | 2422 | 0.010 |
Why?
|
| Sulfonamides | 1 | 1993 | 1933 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2011 | 4329 | 0.010 |
Why?
|
| Gene Expression | 2 | 2001 | 3642 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2010 | 4001 | 0.010 |
Why?
|
| Radiography | 1 | 2006 | 1986 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 2001 | 29 | 0.010 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2001 | 25 | 0.010 |
Why?
|
| Receptors, Cholecystokinin | 1 | 2001 | 29 | 0.010 |
Why?
|
| Colic | 1 | 2001 | 14 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2001 | 121 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2011 | 4117 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2001 | 387 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 848 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 7237 | 0.010 |
Why?
|
| Craniotomy | 1 | 2000 | 304 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2000 | 392 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2011 | 5231 | 0.010 |
Why?
|
| Benzophenanthridines | 1 | 1997 | 8 | 0.010 |
Why?
|
| Phenanthridines | 1 | 1997 | 11 | 0.010 |
Why?
|
| Alkaloids | 1 | 1997 | 85 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 22480 | 0.010 |
Why?
|
| Biological Transport | 1 | 1997 | 627 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2001 | 1825 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 1134 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1995 | 107 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 17043 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2001 | 1933 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 7665 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 1946 | 0.010 |
Why?
|